Shoals Technologies Group, Inc. Class A SHLS 深 沪
交易中 04-06 11:39:00 美东时间
6.73
-0.090
-1.32%
华盛通- 最 高6.92
- 今 开6.80
- 成交量 48.23万股
- 最 低 6.71
- 昨 收 6.82
- 总市值 11.29亿
- 52周最高 11.36
- 市盈率 静 33.75
- 换手率 0.29%
- 52周最低 2.92
- 委 比 62.70%
- 总股本 1.68亿
- 历史最高 44.04
- 量 比 0.40
- 振 幅 3.08%
- 历史最低 2.71
- 每 手 1
- 风险率 2.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Shoals Technologies Group, Inc. Announces BESS Virtual Webinar with Barclays
Shoals Technologies Group Inc., a global leader in electrical infrastructure solutions for the energy transition market, will participate in a virtual webinar hosted by Barclays tomorrow, March 31, 2026. Shoals’ President, Jeff Tolnar, and BESS Product Line Manager, Kishan Ponnadurai, will discuss the company’s BESS products, market paths, and competitive advantages. The webinar, moderated by Christine Cho, is open to the public. Registration det...
03-30 20:30
期权扫描 | 大摩喊话Robotaxi“飞轮效应”启动，特斯拉期权成交登顶NO.1；AMD看跌期权占比升破六成
大摩喊话Robotaxi“飞轮效应”启动，特斯拉期权成交登顶NO.1；与三星合作落地仍难掩谨慎情绪！AMD看跌期权占比升破六成>>
03-19 19:40
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
Jefferies Maintains Buy on Shoals Technologies Group, Lowers Price Target to $8
Jefferies analyst Julien Dumoulin-Smith maintains Shoals Technologies Group (NASDAQ:SHLS) with a Buy and lowers the price target from $10 to $8.
03-12 03:08
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
Analyst Expectations For Shoals Technologies Group's Future
10 analysts have expressed a variety of opinions on Shoals Technologies Group (...
02-27 06:00
What's Going On With Shoals Technologies Shares On Thursday?
Shoals Technologies shares fall following an EPS miss and multiple analyst price target reductions despite steady revenue and strong backlog.
02-27 01:28
美股大行评级 | 大摩将应用材料目标价升至432美元；潜在涨幅200.0%！维尔生物科技获巴克莱升目标价至30美元，维持"超配"评级
今日重点评级关注：巴克莱：维持Vir Biotechnology"超配"评级，目标价从26美元升至30美元；巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从10美元升至11美元
02-26 09:30
Shoals Technologies shares are trading lower after the company reported worse-than-expected Q4 EPS results.
Shoals Technologies shares are trading lower after the company reported worse-t...
02-25 00:46
Shoals Technologies declines as Q1 outlook signals sharp slowdown
Shoals Technologies Group Inc. (SHLS) shares plunged 8.4% in premarket trading Tuesday after the maker of social electrical components posted a modest quarterly revenue beat but missed expectations fo...
02-24 22:02
